Alice T. Wang

Alice T. Wang

Auto-generated profile, based on publicly available information

Alice T. Wang

Division of Plastic Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LMLaura M. Marquardt
Laura M. Marquardt
VDVanessa M. Doulames
Vanessa M. Doulames
AWAlice T. Wang
Alice T. Wang
KDKaren Dubbin
Karen Dubbin
RSRiley A. Suhar
Riley A. Suhar
Sarah HeilshornSarah Heilshorn
Sarah Heilshorn
An injectable gel improves cell transplantation therapy for spinal cord injury.

22 November 2022 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
AWAlice T Wang
Alice T Wang
APAdriana C Panayi
Adriana C Panayi
SFSebastian Fischer
Sebastian Fischer
YDYannick F Diehm
Yannick F Diehm
CTChristian Tapking
Christian Tapking
Valentin HaugValentin Haug
Valentin Haug
The Breast-Q questionnaire reduction module is an established tool for outcomes after reduction mammoplasty. This systematic review and meta-analysis assess key parameters affecting pre- and postoperative scores, with specific foci on patient characteristics and tissue resection weights. This study was conducted per PRISMA guidelines. PUBMED, Google Scholar, and Web of Science were searched. All studies published before August 1st, 2021, were assessed for eligibility by two independent reviewers. Inclusion criteria were prospective or retrospective studies in six languages that reported quality of life after reduction mammoplasty using the Breast-Q questionnaire reduction module. Quality of included studies was assessed using the Newcastle-Ottawa-Scale. Analysis was performed per Cochrane Collaboration and the Quality of Reporting of Meta-analyses (QUOROM) guidelines. 28 papers were included in the systematic review, 13 for preoperative meta-analysis, and 17 for postoperative meta-analysis. Postoperative scores in all three quality of life domains (psychosocial, physical, and sexual wellbeing) and satisfaction with breasts increased significantly after reduction mammoplasty compared to preoperative scores. Satisfaction with breasts showed the greatest improvement, from 22.9 to 73.0. Preoperative scores were lower than normative data, with improvement to comparable scores as the healthy population postoperatively. Improvements in Breast-Q scores did not correlate with patient comorbidities, complication rates, or amount of breast tissue resected. Reduction mammoplasty provides marked improvement in Breast-Q patient-reported quality of life as well established in literature. However, these improvements do not correlate with tissue resection weights, warranting further inquiry of insurance-defined resection requirements.

16 January 2022 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
Valentin HaugValentin Haug
Valentin Haug
NKNikita Kadakia
Nikita Kadakia
AWAlice T. Wang
Alice T. Wang
MDMiguel Dorante
Miguel Dorante
APAdriana Panayi
Adriana Panayi
BPBohdan Pomahac
Bohdan Pomahac

17 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Valentin HaugValentin Haug
Valentin Haug
YPYifeng Peng
Yifeng Peng
BTBianief Tchiloemba
Bianief Tchiloemba
AWAlice T. Wang
Alice T. Wang
FBFlorian Buerger
Florian Buerger
BPBohdan Pomahac
Bohdan Pomahac
Background: Normothermic ex situ perfusion of vascularized composite allografts (VCAs) necessitates high oxygen demand and, thus, increased metabolic activity, which, in turn, requires the use of blood-based perfusion solutions. However, blood-derived perfusates, in turn, constitute an antigenic load. To circumvent this immunogenic problem, we used a perfusate enriched with acellular dextrane oxygen microcarriers to perfuse rat hindlimbs. Methods: Rat hindlimbs (n = 11) were perfused with either (non-), oxygenated dextrane-enriched Phoxilium, or Phoxilium enriched with dextrane oxygen microcarriers (MO2) for 12 h at 37 °C or stored on ice. Oxygenation of the skeletal muscle was assessed with Raman spectroscopy, tissue pO2-probes, and analysis of the perfusate. Transmission electronic microscopy was utilized to assess the ultrastructure of mitochondria of the skeletal muscle. Results: For all evaluated conditions, ischemia time until perfusion was comparable (22.91 ± 1.64 min; p = 0.1559). After 12 h, limb weight increased significantly by at least 81%, up to 124% in the perfusion groups, and by 27% in the static cold storage (SCS) group. Raman spectroscopy signals of skeletal muscle did not differ substantially among the groups during either perfusion or static cold storage across the duration of the experiment. While the total number of skeletal muscle mitochondria decreased significantly compared to baseline, mitochondrial diameter increased in the perfusion groups and the static cold storage group. Conclusion: The use of oxygen microcarriers in ex situ perfusion of VCA with acellular perfusates under normothermic conditions for 12 h facilitates the maintenance of mitochondrial structure, as well as a subsequent recovery of mitochondrial redox status over time, while markers of muscle injury were lower compared to conventional oxygenated acellular perfusates.

1 September 2021 in Journal of Reconstructive Microsurgery
Verified
Journal Article
Closed access
PDF file
MDMiguel Dorante
Miguel Dorante
BKBranislav Kollar
Branislav Kollar
MBMarian Bittner
Marian Bittner
AWAlice Wang
Alice Wang
YDYannick Diehm
Yannick Diehm
BPBohdan Pomahac
Bohdan Pomahac
Background An objective, non-invasive method for redness detection during acute allograft rejection in face transplantation (FT) is lacking. Methods A retrospective cohort study was performed with 688 images of 7 patients with face transplant (range, 1 to 108 months post-transplant). Healthy controls were matched to donor age, sex, and had no prior facial procedures. Rejection state was confirmed via tissue biopsy. An image-analysis software developed alongside VicarVision (Amsterdam, Netherlands) was used to produce R, a measure of differences between detectable color and absolute red. R is inversely proportional to redness, where lower R values correspond to increased redness. Linear mixed models were used to study fixed effect of rejection state on R values. Estimated marginal means of fitted models were calculated for pairwise comparisons. Results Of 688 images, 175, 170, 202, and 141 images were attributable to Banff Grade 0,1,2, and 3, respectively. Estimated change in R value of facial allografts decreased with increasing Banff Grade (p = 0.0001). The mean R value of clinical rejection (Banff Grade ⅔) (16.67, 95% Confidence Interval [CI] 14.79–18.58) was lower (p = 0.005) than non-rejection (Banff Grade 0/1) (19.38, 95%CI 17.43–21.33). Both clinical and non-rejection mean R values were lower (p = 0.0001) than healthy controls (24.12, 95%CI 20.96–27.28). Conclusion This proof-of-concept study demonstrates that software-based analysis can detect and monitor acute rejection changes in FT. Future studies should expand on this tool's potential application in telehealth and as a screening tool for allograft rejection. * Miguel I. Dorante and Branislav Kollar have contributed equally to this manuscript. Received: 30 April 2021 Accepted: 19 July 2021 Publication Date: 01 September 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

13 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HKHarriet Kiwanuka
Harriet Kiwanuka
AWAlice T. Wang
Alice T. Wang
DODennis P. Orgill
Dennis P. Orgill
Regenerative medicine aims to replace damaged cells and tissues following injury